The Weight-Loss Drugs Craze Is Going Strong. But Stock Investors Should Know A Few Things.

Wall Street enjoyed a guilt-free feast in 2024 as shares of Novo Nordisk (NVO), Eli Lilly (LLY) and other makers of weight-loss drugs skyrocketed. But a shift in investor appetites then sent key players' stocks into free fall. Is the party over?

This Dancing Elephant Stomps All Magnificent 7 Stocks Except Google, Even Eclipsing Nvidia

One Man Made More Money On 'Magnificent 7' Stocks Than Anyone Else

Top Funds Gobble Up These 4 Stocks — And Nibble On Nvidia, Palantir

Best Bond ETFs Are Looking Pretty Attractive Right Now

Today's Spotlight

David Ryan’s Ants Indicator spots stocks under heavy accumulation—try it in MarketSurge today.

Learn More >

Join IBD’s experts on 11/11 to learn tips for finding market leaders within top industries.

Want to trade stocks like a pro? Join IBD Live to watch and discuss the market action with a team of top market analysts.

Get Market Insights >

Investor's Business Daily - a Dow Jones affiliate

IBD, IBD Digital, IBD Live, IBD Weekly, Investor's Business Daily, Leaderboard, MarketDiem, MarketSurge and other marks are trademarks owned by Investor's Business Daily, LLC.

Sent to: dupa@niepodam.pl

Investor's Business Daily, LLC, PO Box 300, Princeton, NJ 08543-0300

Need help? Have feedback? Feel free to contact us

Terms of Use | Privacy Notice | Manage Subscriptions | Unsubscribe

ID: 7133